Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prothromplex Total for VKA Reversal
NCT01159210Phase 4Completed
- Sponsor
- Takeda
- Start
- Jul 2010
- Primary completion
- Apr 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 4, open-label, single-arm trial of Prothromplex Total in Acquired deficiency of prothrombin complex coagulation factors, sponsored by Takeda. Primary endpoint: Proportion of subjects who achieve normalisation of International normalised ratio (INR) to <= 1.3 at 30 minutes. Started Jul 2010; status: completed.
02
Drugs
Prothromplex Total
03
Conditions
Acquired deficiency of prothrombin complex coagulation factors
Beyond the preview
Go deeper on NCT01159210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01159210.